Prevalence and Predictors of Polypharmacy and Medication Adherence among Elderly Patients in Benghazi - Libya.

Authors

  • Lina Salama University of Benghazi
  • Abdulla Al-Maedani
  • Mohannad Bengharbia
  • Hussein Aljafil

DOI:

https://doi.org/10.37376/benunivmedj.v2i1.7363

Keywords:

polypharmacy, medication adherence, elderly, Benghazi, comorbidities

Abstract

Background: Polypharmacy is the simultaneous use of five or more prescription medications and its global prevalence is estimated to be 37% and even higher among the elderly. Variable factors could lead to polypharmacy; either related to health-care providers or patients. It is often associated with several negative health and economical outcomes, especially among older patients.
Aim: To assess the prevalence and factors associated with polypharmacy and medication adherence among elderly patients in Benghazi, Libya.
Method: It is a descriptive cross-sectional study that was conducted for a period of five months among elderly patients in Benghazi. The data from 100 subjects was collected through a face-to-face interview using a questionnaire that consisted of two main domains; demographic data (e.g. gender, age, nationality) and clinical data (e.g. number of drugs taken regularly, self-medication, level of drug compliance).
Results: Polypharmacy was observed in 32% of the cases and it was associated with some factors such as older age, certain types of marital status, lower education level and recent hospital/emergency admission. Most of the participants scored low (67%) for the Morisky medication adherence scale followed by medium (21%) and high scores (12%), respectively.
Conclusion: Elderly patients in Benghazi frequently used five or more prescription medications at the same time and mostly did not adhere well to their treatment regimens. These problems could be addressed through several strategies such as continuously assessing patients’ medication regimens and providing extensive patient education.

Author Biographies

Lina Salama, University of Benghazi

Lecturer at the department of Pharmaceutics, Faculty of Pharmacy, University of Benghazi.

Abdulla Al-Maedani

Community pharmacist.

Mohannad Bengharbia

Community pharmacist.

Hussein Aljafil

Community pharmacist.

References

Bhagavathula, A. S., Vidyasagar, K., Chhabra, M., Rashid, M., Sharma, R., Bandari, D. K., & Fialova, D. (2021). Prevalence of polypharmacy, hyperpolypharmacy and potentially inappropriate medication use in older adults in India: A systematic review and meta-analysis. Frontiers in Pharmacology, 12, 685518. https://doi.org/10.3389/fphar.2021.685518

Payne, R. A., & Avery, A. J. (2011). Polypharmacy: One of the greatest prescribing challenges in general practice. The British Journal of General Practice: The Journal of the Royal College of General Practitioners, 61(583), 83–84. https://doi.org/10.3399/bjgp11X556146

Reason, B., Terner, M., Moses McKeag, A., Tipper, B., & Webster, G. (2012). The impact of polypharmacy on the health of Canadian seniors. Family Practice, 29(4), 427–432. https://doi.org/10.1093/fampra/cmr124

Chen, C., Feng, Z., Fu, Q., Wang, J., Zheng, Z., Chen, H., & Feng, D. (2021). Predictors of polypharmacy among elderly patients in china: The role of decision involvement, depression, and taking Chinese medicine behavior. Frontiers in Pharmacology, 12, 745688. https://doi.org/10.3389/fphar.2021.745688

Hajjar, E. R., Cafiero, A. C., & Hanlon, J. T. (2007). Polypharmacy in elderly patients. The American Journal of Geriatric Pharmacotherapy, 5(4), 345–351. https://doi.org/10.1016/j.amjopharm.2007.12.002

Kim, S., Lee, H., Park, J., Kang, J., Rahmati, M., Rhee, S. Y., & Yon, D. K. (2024). Global and regional prevalence of polypharmacy and related factors, 1997–2022: An umbrella review. Archives of Gerontology and Geriatrics, 124, 105465. https://doi.org/10.1016/j.archger.2024.105465

Tian, F., Chen, Z., & Wu, J. (2022). Prevalence of polypharmacy and potentially inappropriate medications use in elderly Chinese patients: A systematic review and meta-analysis. Frontiers in Pharmacology, 13, 862561.https://doi.org/10.3389/fphar.2022.862561

Bruguerolle, B. (2008). Clinical chronopharmacology in the elderly. Chronobiology International, 25(1), 15. https://doi.org/10.1080/07420520801909247

Rollason, V., & Vogt, N. (2003). Reduction of polypharmacy in the elderly: A systematic review of the role of the pharmacist. Drugs & Aging, 20(11), 817–832. https://doi.org/10.2165/00002512-200320110-00003

Levy, H. B., & Barney, K. F. (2016). Pharmacology, pharmacy, and the aging adult: Implications for occupational therapy. In Occupational Therapy with Aging Adults. Elsevier. https://doi.org/10.1016/B978-0-323-06776-8.00022-0

Rieckert, A., Trampisch, U. S., Klaaßen-Mielke, R., Drewelow, E., Esmail, A., Johansson, T., Keller, S., Kunnamo, I., Löffler, C., Mäkinen, J., Piccoliori, G., Vögele, A., & Sönnichsen, A. (2018). Polypharmacy in older patients with chronic diseases: A cross-sectional analysis of factors associated with excessive polypharmacy. BMC Family Practice, 19(1), 113. https://doi.org/10.1186/s12875-018-0795-5

Alsaad, S. M., AlEraij, S., Alsaad, A. M., AlSaif, H. I., & Bawazeer, G. (2022). Potentially inappropriate medications among elderly with frailty in a tertiary care academic medical center in Saudi Arabia. Healthcare (Basel, Switzerland), 10(8), 1440.https://doi.org/10.3390/healthcare10081440

Yap, A. F., Thirumoorthy, T., & Kwan, Y. H. (2016). Medication adherence in the elderly. Journal of Clinical Gerontology and Geriatrics, 7(2), 64–67. https://doi.org/10.1016/j.jcgg.2015.05.001

Maxwell, C. J., Mondor, L., Pefoyo Koné, A. J., Hogan, D. B., & Wodchis, W. P. (2021). Sex differences in multimorbidity and polypharmacy trends: A repeated cross-sectional study of older adults in Ontario, Canada. PloS One, 16(4),e0250567.https://doi.org/10.1371/journal.pone.0250567

Sarwar, M. R., Iftikhar, S., & Sarfraz, M. (2018). Influence of education level of older patients on polypharmacy, potentially inappropriate medications listed in beer’s criteria, and unplanned hospitalization: A cross-sectional study in Lahore, Pakistan. Medicina (Kaunas, Lithuania), 54(4), 57. https://doi.org/10.3390/medicina54040057

Eltaher, S. M., Araby, E. M. (2019). Prevalence and factors associated with polypharmacy among elderly persons. The Egyptian Journal of Community Medicine, 37(3), 55–61. https://doi.org/10.21608/ejcm.2019.43370

Gokce Kutsal, Y., Barak, A., Atalay, A., Baydar, T., Kucukoglu, S., Tuncer, T., Hizmetli, S., Dursun, N., Eyigor, S., Saridogan, M., Bodur, H., Canturk, F., Turhanoglu, A., Arslan, S., & Basaran, A. (2009). Polypharmacy in the elderly: A multicenter study. Journal of the American Medical Directors Association, 10(7),486–490. https://doi.org/10.1016/j.jamda.2009.03.018

Tan, C., Teng, G. G., Chong, K. J., Cheung, P. P., Lim, A., Wee, H. L., & Santosa, A. (2016). Utility of the morisky medication adherence scale in gout: A prospective study. Patient Preference and Adherence, 10,2449–2457.https://doi.org/10.2147/PPA.S119719

Tominaga, Y., Morisky, D. E., & Mochizuki, M. (2021). A cross-sectional study clarifying profiles of patients with diabetes who discontinued pharmacotherapy: Reasons and consequences. BMC Endocrine Disorders, 21(1), 117. https://doi.org/10.1186/s12902-021-00778-7

Hosseini, S. R., Zabihi, A., Jafarian Amiri, S. R., & Bijani, A. (2018). Polypharmacy among the Elderly. Journal of Mid-Life Health, 9(2), 97–103. https://doi.org/10.4103/jmh.JMH_87_17

Rosa, T. E. da C., Benício, M. H. D., Latorre, M. do R. D. de O., & Ramos, L. R. (2003). Determinant factors of functional status among the elderly. Revista De Saude Publica, 37(1), 40–48. https://doi.org/10.1590/s0034-89102003000100008

Rolnick, S. J., Pawloski, P. A., Hedblom, B. D., Asche, S. E., & Bruzek, R. J. (2013). Patient characteristics associated with medication adherence. Clinical Medicine & Research, 11(2), 54–65. https://doi.org/10.3121/cmr.2013.1113

Bosworth, H. (2010). Improving patient treatment adherence: A clinician’s guide. Springer. https://doi.org/10.1007/978-1-4419-5866-2

Jimmy, B., & Jose, J. (2011). Patient medication adherence: Measures in daily practice. Oman Medical Journal, 26(3), 155–159.https://doi.org/10.5001/omj.2011.38

- Jin, H., Kim, Y., & Rhie, S. J. (2016). Factors affecting medication adherence in elderly people. Patient Preference and Adherence, 10, 2117–2125. https://doi.org/10.2147/PPA.S118121

Punnapurath, S., Vijayakumar, P., Platty, P. L., Krishna, S., & Thomas, T. (2021). A study of medication compliance in geriatric patients with chronic illness. Journal of Family Medicine and Primary Care, 10(4), 1644–1648.https://doi.org/10.4103/jfmpc.jfmpc_1302_20

Pasina, L., Brucato, A. L., Falcone, C., Cucchi, E., Bresciani, A., Sottocorno, M., Taddei, G. C., Casati, M., Franchi, C., Djade, C. D., & Nobili, A. (2014). Medication non-adherence among elderly patients newly discharged and receiving polypharmacy. Drugs & Aging, 31(4), 283–289. https://doi.org/10.1007/s40266-014-0163-

Downloads

Published

2025-07-10

How to Cite

Salama, L. ., Al-Maedani, A. ., Bengharbia, M. ., & Aljafil, H. (2025). Prevalence and Predictors of Polypharmacy and Medication Adherence among Elderly Patients in Benghazi - Libya. Benghazi University Medical Journal, 2(1), 108–131. https://doi.org/10.37376/benunivmedj.v2i1.7363

Issue

Section

Articles